These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25573001)

  • 1. Cost-effectiveness analysis of the Xpert MTB/RIF assay for rapid diagnosis of suspected tuberculosis in an intermediate burden area.
    You JH; Lui G; Kam KM; Lee NL
    J Infect; 2015 Apr; 70(4):409-14. PubMed ID: 25573001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of Xpert MTB/RIF performed on bronchial washings obtained in patients with suspected pulmonary tuberculosis in a high prevalence setting.
    Barnard DA; Irusen EM; Bruwer JW; Plekker D; Whitelaw AC; Deetlefs JD; Koegelenberg CF
    BMC Pulm Med; 2015 Sep; 15():103. PubMed ID: 26377395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of Xpert® MTB/RIF on bronchoscopy specimens in patients with suspected pulmonary tuberculosis.
    Lee HY; Seong MW; Park SS; Hwang SS; Lee J; Park YS; Lee CH; Lee SM; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2013 Jul; 17(7):917-21. PubMed ID: 23621953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Analysis of Xpert MTB/RIF for Multi-Outcomes of Patients With Presumptive Pulmonary Tuberculosis in Thailand.
    Khumsri J; Hanvoravongchai P; Hiransuthikul N; Chuchottaworn C
    Value Health Reg Issues; 2020 May; 21():264-271. PubMed ID: 32388198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia.
    Kaso AW; Hailu A
    PLoS One; 2021; 16(10):e0259056. PubMed ID: 34695153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.
    Opota O; Senn L; Prod'hom G; Mazza-Stalder J; Tissot F; Greub G; Jaton K
    Clin Microbiol Infect; 2016 Jul; 22(7):613-9. PubMed ID: 27139592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incremental cost-effectiveness of the second Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis].
    Wang SQ; Sun Q; Jiang GL; Fu YY; Shang YY; Huang HR; Wang GR
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):432-437. PubMed ID: 31189229
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States.
    Choi HW; Miele K; Dowdy D; Shah M
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1328-35. PubMed ID: 24025386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of the Xpert® MTB/RIF assay for tuberculosis diagnosis in Brazil.
    Pinto M; Steffen RE; Cobelens F; van den Hof S; Entringer A; Trajman A
    Int J Tuberc Lung Dis; 2016 May; 20(5):611-8. PubMed ID: 27084814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    Li J; Yip BHK; Leung C; Chung W; Kwok KO; Chan EYY; Yeoh E; Chung P
    PLoS One; 2018; 13(1):e0189531. PubMed ID: 29293514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost analysis of different diagnostic algorithms for pulmonary tuberculosis varying in placement of Xpert MTB/RIF.
    Chadha VK; Sebastian G; Kumar P
    Indian J Tuberc; 2016 Jan; 63(1):19-27. PubMed ID: 27235940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a Single Xpert MTB/RIF Assay to Determine the Duration of Airborne Isolation in Hospitalized Patients With Suspected Pulmonary Tuberculosis.
    Poonawala H; Leekha S; Medina-Moreno S; Filippell M; Johnson JK; Redfield RR; Saharia KK
    Infect Control Hosp Epidemiol; 2018 May; 39(5):590-595. PubMed ID: 29582718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
    Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.
    O'Grady J; Bates M; Chilukutu L; Mzyece J; Cheelo B; Chilufya M; Mukonda L; Mumba M; Tembo J; Chomba M; Kapata N; Maeurer M; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Clin Infect Dis; 2012 Nov; 55(9):1171-8. PubMed ID: 22806590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do we need transbronchial lung biopsy if we have bronchoalveolar lavage Xpert® MTB/RIF?
    Mok Y; Tan TY; Tay TR; Wong HS; Tiew PY; Kam JW; Siao C
    Int J Tuberc Lung Dis; 2016 May; 20(5):619-24. PubMed ID: 27084815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa.
    Van Rie A; Page-Shipp L; Hanrahan CF; Schnippel K; Dansey H; Bassett J; Clouse K; Scott L; Stevens W; Sanne I
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):368-72. PubMed ID: 23407225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing Big Data to Optimize an Algorithm for Rapid Diagnosis of Pulmonary Tuberculosis in a Real-World Setting.
    Peng J; Song J; Wang F; Zuo P; Lu Y; Liu W; Tian L; Chen Z; Zhu Y; Wang X; Shen N; Wang X; Wu S; Yu Q; Vallance BA; Jacobson K; Sun Z; Yu HB
    Front Cell Infect Microbiol; 2021; 11():650163. PubMed ID: 33816355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis.
    Scherer LC; Sperhacke RD; Ruffino-Netto A; Rossetti ML; Vater C; Klatser P; Kritski AL
    BMC Infect Dis; 2009 Dec; 9():216. PubMed ID: 20043842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.